Time allows Regulation Impact Statement on codeine: PSA

white pills and tablets: GMiA
The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed by the deferral must be used to prepare a full Regulation Impact Statement on the proposal to reschedule codeine. Demarte says the PSA in its

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Australia the 'lucky country' in antibiotic resistance
Next New antibiotic from MSD